Biomedical Research Centre developing enhanced cells as... (atients. We look forward to doing this ...)

Biomedical Research Centre developing enhanced cells as therapies

Date:9/2/2009

atients. We look forward to doing this within our hospital environment, in state-of-the-art facilities that are being purpose-built for innovative clinical research."

This research programme is an exciting endeavour for the comprehensive Biomedical Research Centre and for King's Health Partners, one of only five accredited Academic Health Science Centres in the UK, involving King's College London, and Guy's and St Thomas', King's College Hospital and South London and Maudsley NHS Foundation Trusts.

Professor Robert Lechler, Director of King's Health Partners, said: "This research programme will potentially lead to King's Health Partners being among the first to test novel 'enhanced' cell therapies in patients. This is just the kind of translational research that is central to the work of the Biomedical Research Centre and to King's Health Partners research that depends on the active participation of local patients. We certainly benefit hugely from their involvement and they will be the first to benefit from our progress."

'/>"/>

Contact: Andrea Ttofa
andrea.ttofa@gstt.nhs.uk
44-207-188-5577
King's College London
Source:Eurekalert

0

GOOD

Page: 1 2 3
Related medicine news :

1. Environmental Tectonics Corporations BioMedical Systems Division Announces First BARA-MED(R) Monoplace Hyperbaric Chamber Sale in Romania
2. New test for safer biomedical research results
3. Successful Beginning for Wellstone Muscular Dystrophy Center at Boston Biomedical Research Institute
4. 17 of Americas Most Promising Scientists Selected as 2009 Pew Scholars in the Biomedical Sciences
5. Response Biomedical Corporation Announces Appointment of Vice President Finance & Administration and Chief Financial Officer
6. Entest BioMedical Inc. Adds Former National Cancer Institute Researcher to Scientific Advisory Board With Focus on Stem Cell Cancer Patient Therapies
7. New Video Series Spotlights Role of Biomedical Engineers in Caring for Total Artificial Heart Patients
8. Response Biomedical Closes $12.65 million Unit Offering
9. Garth Fisher, M.D., F.A.C.S., World Renowned Plastic Surgeon and Co-Founder Of CellCeuticals(R) Biomedical Skin Treatments Revealed On E!s Keeping Up With The Kardashians as the Surgeon Behind Bruce Jenners New Face
10. Response Biomedical Announces Proposed Unit Offering
11. Dr. Abbott J. Krieger Joins Avery Biomedical Devices, Inc. as Chief Clinical Liaison

Post Your Comments:

(Date:12/17/2009)... AlloSource, one of the nation,s largest non-profit providers of ... surgical procedures and the world,s largest processor of live ... been selected as a finalist in the 2010 Colorado ... Institute category honoring non-profits. This is the second year ... a finalist by the annual awards program, now in ...

(Date:12/17/2009)... "Based on our data, the molecular mechanism of infection ... says Klemens Rottner, head of the HZI research group ... in the current issue of the scientific journal " ... adaptive bacteria. They can live in the presence and ... The ingestion by humans occurs mainly via contaminated egg ...

(Date:12/17/2009)... screening within year of first intercourse , , THURSDAY, Dec. ... U.S. cities, about half acquire at least one of ... trichomoniasis -- within two years of becoming sexually active, ... 381 girls, aged 14 to 17, also found that ... infections. , "Depending on the organism, within four to ...

(Date:12/17/2009)... -- Over the last few weeks there has been ... is used by e cigarette opposition in an attempt ... are questioning the tactics of these groups when the ... safer alternative to tobacco according to several studies, lab ... specialist around the world. ,, Special interest groups ...

(Date:12/17/2009)... care expert announces the release of her new book “Priceless Caregiving: ... a contributing author and the primary compiler of stories for one ... Now released in paperback, Priceless Caregiving can be ordered through Amazon.com ... ... Louis, MO (PRWEB) December 17, 2009 -- Valerie VanBooven RN BSN ...

Breaking Medicine News(10 mins):Health News:AlloSource Recognized for Exemplifying Ethics Amongst Colorado Non-Profits 2 Health News:AlloSource Recognized for Exemplifying Ethics Amongst Colorado Non-Profits 3 Health News:Invasion without a stir 2 Health News:STDs Common Among Sexually Active Teen Girls in Cities 2 Health News:Special Interest Deceptions Continue to Rampant About Electronic Cigarettes 2 Health News:Valerie VanBooven RN BSN Announces the Release of her 3rd Book Celebrating Caregivers and Families 2 Health News:Valerie VanBooven RN BSN Announces the Release of her 3rd Book Celebrating Caregivers and Families 3

[0] AlloSource Recognized for Exemplifying Ethics Amongst Colorado Non-Profits [0] Invasion without a stir [0] STDs Common Among Sexually Active Teen Girls in Cities [0] Special Interest Deceptions Continue to Rampant About Electronic Cigarettes [0] Valerie VanBooven RN BSN Announces the Release of her 3rd Book Celebrating Caregivers and Families

... conjoined from the breast bone to the groinPITTSBURGH, Feb. ... nurses at Children,s Hospital of Pittsburgh of UPMC has ... twin girls -- Dagian and Danielle Lee, of Cleveland ... 6:30 a.m. Saturday, Dec. 13, 2008, and ended 24 ...

... nation,s leading provider of telemedicine health services, today ... service that connects remote workers with physicians through ... telemedicine technology and medical services to improve workforce ... and remote workers gain access to advanced healthcare, ...

... N.C., Feb. 16 AlphaVax announced ... as Vice President of Regulatory, Quality and Clinical ... and strategic direction in the areas of regulatory ... in directing successful clinical trials, developing regulatory strategy ...

... remains unclear , , MONDAY, Feb. 16 (HealthDay News) -- ... blood pressure in humans has linked variant versions of ... with high blood pressure, a major risk factor for ... of genes and gene variants reported to be related ...

... DRE, a premier medical and surgical equipment supplier, expands its ... , ... (Vocus) February 16, 2009 ... the Year by Business First of Louisville — now sells ...

... physiological effects of trauma, study finds , , SUNDAY, Feb. ... memories from the fear and anxiety they produce with just ... from Dutch researchers published in the Feb. 15 advance online ... colleagues used a beta blocker called propranolol (Inderal) to erase, ...

Conjoined Twins Separated by Surgical Team at Children's Hospital of Pittsburgh of UPMC During Complex, 24-Hour Procedure InPlace Medical Solutions Announces Advanced Medical Services for Offshore and Remote Locations AlphaVax Announces New Vice President of Regulatory, Quality and Clinical Operations Genes That Control Body's Salt Levels Are Identified DRE Adds Professionally Refurbished Endoscopy Products to Online Catalog Beta Blocker Blocks Feelings of Bad Memories

(Date:12/17/2009)... Dec. 17 Frost & Sullivan ... American Healthcare Innovation Award in molecular diagnostics ... its commitment to providing innovative technologies for ... its incorporation in 2004, IntelligentMDx has introduced ... to make tests that are clinically impactful, ...

(Date:12/17/2009)... Mass., Dec. 17 Decision Resources, one ... focusing on pharmaceutical and healthcare issues, finds that ... there is a high need for diabetes drugs ... who say there is a high need for ... favor agents with excellent glucose lowering ability and ...

(Date:12/16/2009)... Dec. 17 Cell Therapeutics, Inc. ... that on February 10, 2010 the U.S. ... Committee (ODAC) will review the New Drug ... of relapsed/refractory aggressive non-Hodgkin,s lymphoma (NHL). ODAC ... evaluates data concerning the efficacy and safety ...

Breaking Medicine Technology:Frost & Sullivan Recognizes IntelligentMDx for Its Commitment to the Advancement of Healthcare and Diagnostics 2 Frost & Sullivan Recognizes IntelligentMDx for Its Commitment to the Advancement of Healthcare and Diagnostics 3 Frost & Sullivan Recognizes IntelligentMDx for Its Commitment to the Advancement of Healthcare and Diagnostics 4 Frost & Sullivan Recognizes IntelligentMDx for Its Commitment to the Advancement of Healthcare and Diagnostics 5 Over 70 Percent of Physicians Say There Is a High Need for More Diabetes Drugs with Novel Mechanisms of Action While 15 Percent Say the Same for DPP-IV Inhibitors 2 Over 70 Percent of Physicians Say There Is a High Need for More Diabetes Drugs with Novel Mechanisms of Action While 15 Percent Say the Same for DPP-IV Inhibitors 3 Cell Therapeutics Announces FDA's Oncologic Drugs Advisory Committee to Review Pixantrone for the Treatment of Relapsed/Refractory Aggressive Non-Hodgkin's Lymphoma, February 10, 2010 2 Cell Therapeutics Announces FDA's Oncologic Drugs Advisory Committee to Review Pixantrone for the Treatment of Relapsed/Refractory Aggressive Non-Hodgkin's Lymphoma, February 10, 2010 3 Cell Therapeutics Announces FDA's Oncologic Drugs Advisory Committee to Review Pixantrone for the Treatment of Relapsed/Refractory Aggressive Non-Hodgkin's Lymphoma, February 10, 2010 4 Senator Proposes Use of Internet Gambling Revenue to Help Fund Health Care Reform 57860 1 Senator Proposes Use of Internet Gambling Revenue to Help Fund Health Care Reform 57860 2 New Report Highlights Proven Disease Prevention Programs in Communities 57858 1 New Report Highlights Proven Disease Prevention Programs in Communities 57858 2 New Report Highlights Proven Disease Prevention Programs in Communities 57858 3 New Report Highlights Proven Disease Prevention Programs in Communities 57858 4 MedImmune Receives U S Government Order for Additional 29 Million Doses of Nasal Spray Vaccine for 2009 H1N1 Influenza 57856 1 MedImmune Receives U S Government Order for Additional 29 Million Doses of Nasal Spray Vaccine for 2009 H1N1 Influenza 57856 2 MedImmune Receives U S Government Order for Additional 29 Million Doses of Nasal Spray Vaccine for 2009 H1N1 Influenza 57856 3

[0] Frost & Sullivan Recognizes IntelligentMDx for Its Commitment to the Advancement of Healthcare and Diagnostics [0] Over 70 Percent of Physicians Say There Is a High Need for More Diabetes Drugs with Novel Mechanisms of Action While 15 Percent Say the Same for DPP-IV Inhibitors [0] Cell Therapeutics Announces FDA's Oncologic Drugs Advisory Committee to Review Pixantrone for the Treatment of Relapsed/Refractory Aggressive Non-Hodgkin's Lymphoma, February 10, 2010

... -- Scientists,at WEHI have made a discovery with ... those undergoing,cancer chemotherapy. , The research team led ... that platelet life span is controlled by two ... a new,drug to prolong the life span of ...

... La.--(BUSINESS WIRE)--Mar 26, 2007 - A study comparing,the ... in V-HeFT I and V-HeFT II, and BiDil, ... American Heart Failure,Trial (A-HeFT) demonstrated no bioequivalence. Non-bioequivalence,in ... and V-HeFT II,showed very different results in decreasing ...

Other Medicine Technology:Major Discovery Raises Prospect of Better Patient Care By Improving,Platelet Life Span 2 Major Discovery Raises Prospect of Better Patient Care By Improving,Platelet Life Span 3 Study: Identical Doses of BiDil Components Are Not Bioequivalent to,the Fixed Dose Combination-BiDil-Used in A-HeFT 2 Study: Identical Doses of BiDil Components Are Not Bioequivalent to,the Fixed Dose Combination-BiDil-Used in A-HeFT 3 Study: Identical Doses of BiDil Components Are Not Bioequivalent to,the Fixed Dose Combination-BiDil-Used in A-HeFT 4 Study: Identical Doses of BiDil Components Are Not Bioequivalent to,the Fixed Dose Combination-BiDil-Used in A-HeFT 5

Major Discovery Raises Prospect of Better Patient Care By Improving,Platelet Life Span Study: Identical Doses of BiDil Components Are Not Bioequivalent to,the Fixed Dose Combination-BiDil-Used in A-HeFT

... The BD Safety Knife with BD Xstar ... shield that protects the blade in prodedure ... is based on a grind-less process for ... yields outstanding sharpness and consistency. The ...

Electric high speed system....

The Durafuge 100 spins swing-out rotors at 4000 rpm and fixed-angle rotors at up to 6300 rpm....

Prevents formation of microscopic ice crystals and sample distortion caused by slow freezing of hyperosmolar tissue samples in conventional cyrostats....

Medicine Products:

BD™ Safety Knife with BD Xstar™ Blade 2.60 mm Microspeed EC Precision Durafuge® 100 Centrifuge Shandon Histobath 2

Biomedical Research Centre developing enhanced cells as...(atients. We look forward to doing this ...),Health